Lexitas Pharma Services and Ocusun have announced enrollment of the first patient in a pilot study evaluating ZOC2017217, an ...
ZOC2017217, an eye drop aimed at slowing or reversing the development of cataracts, is undergoing a pilot study ahead of a ...
Patients older than 75 years who undergo cataract surgery report more frequent failure of the ocular surface after the procedure than those younger than 65 years; however, the prophylactic ...
Many years ago, I began my PhD with the firm resolve of finding a cure for cataracts – not in several years or decades, but within the duration of my PhD. Such was my enthusiasm and naivety. Decades ...
The Healthy @Reader's Digest on MSN
What I wish I’d known about cataract surgery: A doctor details what patients should know about a common procedure
An expert MD reveals clear insights into cataract surgery, spotlighting the breakthroughs in treatment: "We live in a time of ...
An analysis of past research conducted by the Salt Lake City-based University of Utah Health John A. Moran Eye Center found cause for further testing to determine if cataracts might someday be ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The phase 3 OPTIMIZE trial met both primary efficacy ...
Think blurry vision is just a sign of aging? It could be cataracts. Here are the warning signs and why you should get an exam ...
Lexitas Pharma Services, a leading full-service ophthalmology clinical research organization (CRO), and Ocusun, a high-tech innovative ophthalmic pharmaceutical company, announced the enrollment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results